Channel Avatar

Duke Margolis @UCKA519NlVObjkZnKRfWDkfg@youtube.com

1.8K subscribers - no pronouns :c

The Robert J. Margolis, MD, Institute for Health Policy at D


02:40:47
Medicare Accountable Care in 2025 and Beyond
02:41:15
The Second Annual Future of Prescription Drug Promotion and Digital Marketing Meeting
01:02:04
Addressing Health-Related Social Needs at Scale in Medicaid: The Past, Present, and Future of NC HOP
05:04:58
Continual Improvement of CDER BLA Submission, Assessment, and Facility Readiness/Inspection
04:30:04
2024 State of Real World Evidence Policy
03:43:09
ReVAMPing the Pharmaceutical Supply Chain: Implementing Policy to Prevent Drug Shortages
01:57:50
Advancing Whole-Person Health Care through North Carolina's State Transformation Collaborative
04:40:47
2024 Health Policy Conference: Updating Health Reform for the Next Decade
58:22
Strengthening Whole-person Specialty Care through Accountable Care Innovation
04:21:25
Fostering Collaboration to Advance Representative Enrollment in Clinical Trials
04:07:21
Enhancing Adoption of Innovative Clinical Trial Approaches - Day 2
05:28:20
Enhancing Adoption of Innovative Clinical Trial Approaches - Day 1
01:50:21
Collaborative Short Term Action to Advance America's Health
04:50:40
Advancing Real-World Data to Generate Regulatory Grade Real-World Evidence in Oncology
03:19:32
Advancing Drug Development for the Prevention of Spontaneous Preterm Birth Workshop - Day 2
01:30:28
Translating QbD Principles to Risk-Proportionate Oversight Including RBM: Successes and Challenges
01:11:50
Next Steps for Implementing Quality Management of Clinical Investigations
01:30:51
Risk-Based Approaches to Building Quality into the Design & Conduct of Clinical Investigations
01:27:55
Optimizing Study Design and Setting the Stage for Efficient Study Conduct Through QbD
06:52
Senator Chris Van Hollen - Advancing Hepatitis C Elimination: A Coordinated National Approach
04:49:41
Advancing the Development of Therapeutics Through Rare Disease Patient Community Engagement
54:34
Emerging CMMI Models: Aligning to Reduce Burden & Achieve Person-Centered Care in 2024
01:15:31
Improving Regulatory Practices to Sustain Antibiotic Innovation
59:00
Bridging a Care Gap: Policy Opportunities for Improving Access to Home-Based Primary Care
48:48
Advancing Hepatitis C Elimination Part 2 - Sessions 4 & 5
02:21:05
Advancing Hepatitis C Elimination Part 1 - Sessions 1, 2, & 3
01:00:34
Reimagining our Shared Approach to Fall Respiratory Virus Seasons Session 2
55:21
Reimagining our Shared Approach to Fall Respiratory Virus Seasons Session 3
35:12
Reimagining our Shared Approach to Fall Respiratory Virus Seasons Session 4
01:15:06
Reimagining our Shared Approach to Fall Respiratory Virus Seasons Session 1
01:15:22
15th Annual Sentinel Workshop Keynote and Fireside Chat with Sentinel Initiative Leadership
01:24:49
15th Annual Sentinel Initiative Public Workshop - Sessions 2 & 3
01:31:51
15th Annual Sentinel Initiative Public Workshop - Sessions 4 & 5
02:08:05
15 Annual Sentinel Initiative Public Workshop - Sessions 6 & 7
03:17:28
Medicare Accountable Care in 2030 | The Pathway to 100%
03:51:19
The State of Real-World Evidence Policy 2023
01:01:16
Day 1 - Session 4 - Optimizing the Use of Postapproval Pregnancy Safety Studies
01:23:25
Day 2 -Session 6 - Optimizing the Use of Postapproval Pregnancy Safety Studies
01:27:13
Day 1 - Session 2 - Optimizing the Use of Postapproval Pregnancy Safety Studies
36:45
Day 1 - Session 1 - Optimizing the Use of Postapproval Pregnancy Safety Studies
01:35:29
Day 2 - Session 5 - Optimizing the Use of Postapproval Pregnancy Safety Studies
01:15:40
Day 1 - Session 3 - Optimizing the Use of Postapproval Pregnancy Safety Studies
26:36
Day 1 - FDA Opening Presentation - Optimizing the Use of Postapproval Pregnancy Safety Studies
04:17:16
The Future of Prescription Drug Promotion and Digital Marketing
59:20
Preparedness to Combat Infectious Disease and Drug Resistant Bacterial Threats
03:53:11
Advancing Representative Enrollment in Clinical Trials
05:11:55
Advancing the Utilization and Supporting the Implementation of Innovative Manufacturing Approaches
03:44:31
Rare Disease Endpoint Advancement Pilot Program Workshop Day 1
03:00:34
Rare Disease Endpoint Advancement Pilot Program Workshop Day 2
03:41:58
Duke-Margolis 2023 Health Policy Conference: Reversing the Slide in America's Health
55:33
Drug-Resistant Infections & the Immediate and Future Demand for Novel Antimicrobials
11:47
A Conversation with U.S. Senator Todd Young - Drug Resistant Infections & the Immediate and Future
01:26:21
The Next Generation of Risk Adjustment: Policy Opportunities to Advance Reform
20:00
Leveraging Adult Efficacy Data for Pediatrics Using Bridging Biomarkers
18:40
Use of Surrogate Endpoints in Oncology
18:36
Development and validation of cerebrospinal fluid & blood biomarkers for neurodegenerative diseases
16:39
Hutchinson-Gilford Progeria Syndrome Case Study
11:23
Use of Imported Clinical Assessment Tools in Rare Disease: A Case Study
22:20
Neurofilament Light Chain in Neurodegenerative Diseases – Status Update
18:28
Quantitative Susceptibility Mapping on MRI as a Biomarker of Rebleeding in CASH